Doç. Dr. Hale ATEŞ

1. Rapid drug desensitization to taxanes: a descriptive study from Turkey

Yeşilkaya S., AKSU K., Vural Solak G. T., Demir Ş., Topel M., Erçelebi D. Ç., et al.

Journal of Oncology Pharmacy Practice , cilt.30, sa.8, ss.1358-1363, 2024 (SCI-Expanded, Scopus)

2. What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

Başa Akdoğan B., Koca Kalkan I., KÖYCÜ BUHARİ G., Özdedeoğlu Ö., ATEŞ H., AKSU K., et al.

Journal of Asthma and Allergy , cilt.17, ss.113-122, 2024 (SCI-Expanded, Scopus)

3. Results of omalizumab treatment in chronic eosinophilic pneumonia: Real-life data Kronik eozinofilik pnömonide omalizumab tedavisinin sonuçları: Gerçek yaşam verileri

Başa Akdoğan B., AKSU K., Koca Kalkan İ., KÖYCÜ BUHARİ G., Özdedeoğlu Ö., ATEŞ H., et al.

Tuberkuloz ve Toraks , cilt.72, sa.1, ss.71-81, 2024 (ESCI, Scopus, TRDizin)

4. Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations

KÖYCÜ BUHARİ G., Oner Erkekol F., Koca Kalkan I., ATEŞ H., Vural Solak G. T., Akkale O., et al.

World Allergy Organization Journal , cilt.17, sa.1, 2024 (SCI-Expanded, Scopus)

5. A descriptive study evaluating quality of life and factors affecting it in adult asthmatics Une étude descriptive évaluant la qualité de vie et les facteurs qui l'affectent chez les asthmatiques adultes

Solak G. V., AKSU K., Erçelebi D. Ç., Topel M., Yeşilkaya S., DEMİR Ş., et al.

Revue Francaise d'Allergologie , cilt.63, sa.7, 2023 (SCI-Expanded, Scopus)

6. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions

KÖYCÜ BUHARİ G., Kalkan İ. K., ATEŞ H., NAZİK BAHÇECİOĞLU S., Demir Ş., Yeşilkaya S., et al.

Allergologia et Immunopathologia , cilt.51, sa.2, ss.130-136, 2023 (SCI-Expanded, Scopus)

7. Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience 2011-2021 yılları arasında uygulanan subkutan alerjen immünoterapisine bağlı gelişen yan etkilerin özellikleri: Tek merkez deneyimi

Vural Solak G. T., AKSU K., Solak Y., Demir Ş., Çuhadar Erçelebi D., KÖYCÜ BUHARİ G., et al.

Tuberkuloz ve Toraks , cilt.71, sa.4, ss.356-366, 2023 (ESCI, Scopus, TRDizin)

8. A favipiravir-induced angioedema and urticaria in a COVID-19 patient

Ergur Ozturk F., ÖZTÜRK A., ATEŞ H.

Antiviral Therapy , cilt.27, sa.6, 2022 (SCI-Expanded, Scopus)

9. Successful desensitization under antihistamine suppression in a case with urticaria due to osimertinib

Vural Solak G. T., AKSU K., Topel M., Çuhadar Erçelebi D., Yeşilkaya S., Demir Ş., et al.

Journal of Oncology Pharmacy Practice , cilt.28, sa.6, ss.1454-1457, 2022 (SCI-Expanded, Scopus)

10. Relationships between quality of life, sleep problems, and sleep quality in patients with chronic idiopathic urticaria

ATEŞ H., FIRAT S., KÖYCÜ BUHARİ G., Keren M., Cifci B., Erkekol F. Ö.

Journal of Cosmetic Dermatology , cilt.21, sa.9, ss.4072-4079, 2022 (SCI-Expanded, Scopus)

11. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

DURUSU TANRIÖVER M., Doğanay H. L., AKOVA M., GÜNER H. R., AZAP A., AKHAN S., et al.

The Lancet , cilt.398, sa.10296, ss.213-222, 2021 (SCI-Expanded, Scopus)

12. Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

Koca Kalkan I., ATEŞ H., AKSU K., Yesilkaya S., Topel M., Cuhadar Ercelebi D., et al.

World Allergy Organization Journal , cilt.14, sa.7, 2021 (SCI-Expanded, Scopus)

13. COVID-19 in a patient with severe asthma using mepolizumab

AKSU K., Yesilkaya S., Topel M., Turkyilmaz S., Ercelebi D. C., Oncul A., et al.

Allergy and Asthma Proceedings , cilt.42, sa.2, ss.55-57, 2021 (SCI-Expanded, Scopus)

14. COVID-19 in patients with severe asthma using biological agents

AKSU K., Demir Ş., Topel M., Yeşilkaya S., ATEŞ H., Koca Kalkan İ., et al.

Tuberkuloz ve Toraks , cilt.69, sa.3, ss.433-436, 2021 (ESCI, Scopus, TRDizin)

15. Mycobacterium abscessus infection management: Macrolide and quinolone desensitization Mycobacterium abscessus enfeksiyonu yönetimi: Makrolid ve kinolon desensitizasyonu

AKSU K., Çuhadar Erçelebi D., ÖZKARA Ş., Türkyilmaz S., Koca Kalkan İ., Özdedeoğlu Ö., et al.

Tuberkuloz ve Toraks , cilt.69, sa.3, ss.399-402, 2021 (ESCI, Scopus, TRDizin)

16. Can fractional exhaled Nitric Oxide with blood eosinophil count have a place in the diagnostic algorithm for Asthma?

Koca Kalkan İ., KÖYCÜ BUHARİ G., ATEŞ H., Başa Akdoğan B., Özdedeoğlu Ö., AKSU K., et al.

Asthma Allergy Immunology , cilt.19, sa.2, ss.100-109, 2021 (ESCI, Scopus, TRDizin)

17. Successful desensitization with ferric carboxymaltose

Özdedeoǧlu Ö., AKSU K., Akdoǧan B., ATEŞ H., KÖYCÜ BUHARİ G., Kalkan I., et al.

Asthma Allergy Immunology , cilt.18, sa.1, ss.51-53, 2020 (ESCI, Scopus, TRDizin)

18. Squamous cell cancer of the lung with synchronous renal cell carcinoma

ATEŞ İ., Yazıcı O., ATEŞ H., Yazılıtaş D., Özcan A. N., AĞAÇKIRAN Y., et al.

Turk Toraks Dergisi , cilt.17, sa.3, ss.125-127, 2016 (Scopus)

Doç. Dr. Hale ATEŞ

Yayınlar & Eserler

1. Rapid drug desensitization to taxanes: a descriptive study from Turkey

2. What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

3. Results of omalizumab treatment in chronic eosinophilic pneumonia: Real-life data Kronik eozinofilik pnömonide omalizumab tedavisinin sonuçları: Gerçek yaşam verileri

4. Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations

5. A descriptive study evaluating quality of life and factors affecting it in adult asthmatics Une étude descriptive évaluant la qualité de vie et les facteurs qui l'affectent chez les asthmatiques adultes

6. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions

7. Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience 2011-2021 yılları arasında uygulanan subkutan alerjen immünoterapisine bağlı gelişen yan etkilerin özellikleri: Tek merkez deneyimi

8. A favipiravir-induced angioedema and urticaria in a COVID-19 patient

9. Successful desensitization under antihistamine suppression in a case with urticaria due to osimertinib

10. Relationships between quality of life, sleep problems, and sleep quality in patients with chronic idiopathic urticaria

11. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

12. Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

13. COVID-19 in a patient with severe asthma using mepolizumab

14. COVID-19 in patients with severe asthma using biological agents

15. Mycobacterium abscessus infection management: Macrolide and quinolone desensitization Mycobacterium abscessus enfeksiyonu yönetimi: Makrolid ve kinolon desensitizasyonu

16. Can fractional exhaled Nitric Oxide with blood eosinophil count have a place in the diagnostic algorithm for Asthma?

17. Successful desensitization with ferric carboxymaltose

18. Squamous cell cancer of the lung with synchronous renal cell carcinoma

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim